Top Markets
#1 Black Phoenix Black Phoenix +733.86%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +24.97%
#3 Wrapped STX (Velar) Wrapped STX (Velar) +16.84%
#4 MetaDAO MetaDAO +16.83%
#5 Verus Coin Verus Coin +13.94%
#6 Akedo Akedo +10.08%
#7 Tokamak Network Tokamak Network +6.40%
#8 XYO Network XYO Network +5.56%
#9 Cysic Cysic +5.30%
#10 Prom Prom +5.15%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
Pulse Biosciences, Inc. Pulse Biosciences, Inc.

Pulse Biosciences, Inc.

PLSE
Rank in Stocks #4733
Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric... Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric medicine. Their primary offering is the CellFX System, a sophisticated, console-based platform that is precisely controlled via software. This system utilizes its proprietary Nano-Pulse Stimulation technology to deliver extremely brief, nanosecond-duration electrical pulses. This advanced method is designed to selectively eliminate target cells without thermal damage, effectively safeguarding adjacent non-cellular tissue. The CellFX System is applied in the treatment of various medical conditions. The company, originally incorporated in 2014 as Electroblate, Inc., officially became Pulse Biosciences, Inc. in December 2015. Its corporate headquarters are situated in Hayward, California.
Share Price
$48.46
Last synced: 2026-08-26
Market Cap
$3.35B
Change (1 day)
-1.09%
Change (1 year)
205.77%
Country
US
Trade Pulse Biosciences, Inc. (PLSE)

Category

Healthcare
Revenue for Pulse Biosciences, Inc. (PLSE)
Revenue in Aug 2026 TTM: 0
According to Pulse Biosciences, Inc. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Pulse Biosciences, Inc. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Intuitive Surgical, Inc. Intuitive Surgical, Inc.
Intuitive Surgical, Inc.
ISRG.US
 $11.03B -
US
EssilorLuxottica S.A. EssilorLuxottica S.A.
EssilorLuxottica S.A.
EL.PA
 $34.74B -
FR
HOYA Corporation HOYA Corporation
HOYA Corporation
7741.T
 - -
JP
Becton, Dickinson and Company Becton, Dickinson and Company
Becton, Dickinson and Company
BDX.US
 $20.84B -
US
Alcon Inc. Alcon Inc.
Alcon Inc.
ALC.SW
 - -
CH